PTC
AMED

Petrus Trust Company’s Amedisys AMED Stock Holding History

Petrus Trust Company’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,706
Closed -$493K – 576
2023
Q1 		$493K Buy
6,706
+3,639
+119% +$315K 0.06% 100
2022
Q4 		$256K Buy
+3,067
New +$277K 0.03% 334
2019
Q4 		– Sell
-1,716
Closed -$225K – 284
2019
Q3 		$225K Sell
1,716
-230
-12% -$29.9K 0.04% 186
2019
Q2 		$236K Buy
1,946
+71
+4% +$8.43K 0.04% 173
2019
Q1 		$231K Buy
+1,875
New +$235K 0.04% 192
2018
Q4 		– Sell
-3,122
Closed -$390K – 225
2018
Q3 		$390K Buy
+3,122
New +$345K 0.09% 62
2018
Q1 		– Sell
-6,325
Closed -$333K – 168
2017
Q4 		$333K Buy
+6,325
New +$333K 0.08% 87

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Petrus Trust Company's AMED Position: Q2 2023 in Review

Petrus Trust Company sold out of Amedisys (AMED) in Q2 2023, closing a stake of 6,706 shares — an estimated $493K sold.

Petrus Trust Company first reported a position in AMED in Q4 2017 and held it in 7 quarters. The position peaked at $493K in Q1 2023. 301 funds tracked by Wall St. Rank hold AMED as of Q2 2023.

  • Petrus Trust Company reported no remaining Amedisys position as of Q2 2023 after selling out during the quarter.
  • Petrus Trust Company sold 6,706 Amedisys shares in Q2 2023, an estimated $493K.
  • Petrus Trust Company first reported a position in Amedisys in Q4 2017 and held it in 7 quarters.
  • Petrus Trust Company's Amedisys position peaked at $493K in Q1 2023.
  • 301 funds tracked by Wall St. Rank held Amedisys as of Q2 2023.

Based on Petrus Trust Company's 13F filing for Q2 2023, filed 14 Aug 2023.